«We found that simply alerting patients and providers during an office appointment increased uptake and completion of
the HPV vaccine series.
Completing
the HPV vaccine series before beginning sexual activity reduces risk of infection from the HPV types targeted by the vaccine.
Adjusted for age, race / ethnicity, marital status, education, income, health coverage and routine medical check - ups / flu vaccines, women living in the South were still less likely to initiate or complete
the HPV vaccine series.
Published in The Journal of Rural Health, the study involved research nurses administering the first dose of
the HPV vaccine series free of charge to Appalachian Kentucky women aged 18 - 26.
Teen boys and girls who did not start or finish
the HPV vaccine series when they were younger should get it now.
Not exact matches
The
HPV vaccine - specific educational brochure, designed to motivate parents to start the
series, had mixed results by race / ethnicity.
This clinical trial, which included 1,518 participants, was the basis for the recent approval from the Food and Drug Administration of a 2 - dose
series of the 9 - valent
HPV vaccine for adolescents,» writes Lauri E. Markowitz, M.D., of the U.S. Centers for Disease Control and Prevention, Atlanta, and colleagues in an accompanying editorial.
The authors think that these benefits could facilitate the implementation of
HPV immunization programs in low - income countries, as well as improve the relatively low
vaccine coverage and
series completion rates observed in some developed countries.
HPV vaccines are highly effective in protecting against precancerous lesions and genital warts; nevertheless,
vaccine uptake and
series completion are still low.
To better understand why women who initiate
HPV vaccination do not complete the
series, a team of researchers led by Dr. Abbey Berenson from the University of Texas Medical Branch examined the correlates of
vaccine series completion among young women using data from the Behavioral Risk Factor Surveillance System (BRFSS), a cross-sectional telephone health survey conducted by the Centers for Disease Control and Prevention.
The Centers for Disease Control and Prevention recommends that all girls and boys receive the three - dose
series of the
HPV vaccine between ages 11 and 12 to protect against
HPV - linked cancers, which include those of the cervix and other cancers of the anus and genitals, as well as some head and neck cancers.
HPV vaccines are given in a
series of 3 separate shots over a 6 month period.
HPV vaccines are given in a
series of shots.